Sign up
Pharma Capital
EPIC: ZYNE
Market: NASDAQ
Sector: Pharma & Biotech
Market Cap: $68.57M
Website: zynerba.com

Zynerba’s mission is to develop next-generation transdermally-delivered cannabinoid therapeutics to help address significant unmet medical needs and improve the lives of patients with rare and near-rare neuropsychiatric conditions such as Fragile X syndrome (FXS), Autism Spectrum Disorder (ASD), 22q, and a heterogeneous group of rare and ultra-rare epilepsies known as developmental and...

Zynerba Pharmaceuticals

zynerba.com

Interactive graph

col 3
col 4
col 5
col 6

Zynerba Pharmaceuticals Timeline

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.